Karyotype analysis of amniotic fluid cells

Karyotype analysis (RHG, ~350 bands) from at least 16 metaphases derived from two independent cultures in order to ensure maximum reliability of test results.

The test includes:

NOTE:Our laboratory participates with great success in the external quality assessment scheme provided by UK NEQAS, which is periodically applied for chromosomal diagnosis of amniotic fluid cells.

This test may also be applied in combination with:

* Detection of the F508del mutation does NOT CONSTITUTE a full mutation analysis for cystic fibrosis. We strongly recommend detection of the F508del mutation from a dry blood sample (INO-DRY) during the 1st trimester of gestation (see below).